Article

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s Disease

2026-02-18

Abstract excerpt

Subtle alterations in awareness may emerge in the preclinical stage of Alzheimer’s disease (AD), yet their clinical significance and translational relevance remain unclear. This study aimed to evaluate associations of distinct awareness trajectories with clinical and multimodal AD biomarker measurements in cognitively unimpaired (CU) older adults. This prospective study analyzed data from the Anti-Amyloid Treatmen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bdf07ff0-020e-5b94-9d83-8d9a46a4cf88
DOI: 10.64898/2026.02.16.26346402

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s DiseaseDOI 10.64898/2026.02.16.26346402Read

Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer DiseaseSemantic proximity Read

Scalable Markers for Early Cognitive Decline: Plasma p-tau217, Subjective Cognitive Concerns, and Digital Testing: Results from the A4/LEARN studiesSemantic proximity Read

The PREVENT-AD cohort: accelerating Alzheimer’s disease research and treatment in Canada and beyondSemantic proximity Read

Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer’s Disease PathophysiologySemantic proximity Read

AT(N) predicts near-term development of Alzheimer’s disease symptoms in unimpaired older adultsSemantic proximity Read

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity Read

Predicting future cognitive impairment in preclinical Alzheimer’s disease using multimodal imaging: a multisite machine learning studySemantic proximity Read

Computational Risk Stratification of Preclinical Alzheimer’s in Younger AdultsSemantic proximity Read

Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adultsSemantic proximity Read

Multi-domain AD risk burden and plasma biomarkers in cognitively unimpaired adultsSemantic proximity Read

Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkersSemantic proximity Read

Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocksSemantic proximity Read